In line with this hypothesis, an observational study of 200 adults with type 1 diabetes demonstrated improvements in albuminuria and in eGFR with SGLT2i use over 12 months among adults with a baseline eGFR 7000 participants identified a 2.8-fold greater risk of DKA with SGLT2i use compared with placebo in adults with type 1 diabetes [44]
Evaluating Glycemic Control Efficacy and Safety of the Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis
Practical Steps for Your Prescriber Conversation Bring these three data points to your appointment: Your current dose and how long you have been at that dose Whether you are already using a topical retinoid (and which one) Your pregnancy planning timeline, if applicable Ask specifically about: taper speed, whether a COC makes sense as a bridge, and when to schedule a follow-up skin check (typically 3 months post-discontinuation)
This dual-action strategy not only limits appetite but also promotes long-lasting satisfaction, making smaller meals fulfilling while reducing hunger cues
Usually illegal, often counterfeit, quality unverifiable
